New Page: S&P500 Companies Overview
see insider trading activities and stock performance analytics over the past year - Click here
New Page: S&P500 Companies Overview
see insider trading activities and stock performance analytics over the past year - Click here
Home > NEKTAR THERAPEUTICS
NEKTAR THERAPEUTICS
Industry: Life Sciences ・ $NKTR on Nasdaq ・ Market Cap: Micro
CEO Recent Sales
Top Executive Recent Sales
1Y INSIDER TRADING ACTIVITY
Insider Trade Volume in USD
1Y INSIDER ACTIVITY
| TRADES PURCHASE/SALE Sector Average | 0 / 17 2.19 / 7.65 |
| INSIDER BUYERS/SELLERS Sector Average | 0 / 5 1.2 / 2.5 |
| SHARES PURCHASED/SOLD Transaction Average | 0 / 236,988 0 / 13,940 |
| VALUE PURCHASED/SOLD Transaction Average | $0 / $284,796 $0 / $16,753 |
| PURCHASE RANGE | N/A |
| SALE RANGE | $3,517.71 - $99,680 |
INSIDER PERFORMANCE OVERVIEW
PURCHASE PERFORMANCE
0 / 8
CEO Purchases
Top Executive Purchases
New Purchase Insider
High Purchase Reporters Count
High Purchase Activity
Regular Purchase Insiders
Abnormal High-Volume Purchases
High Purchases Frequency
SALE PERFORMANCE
1 / 4
CEO Sales
Top Executive Sales
Regular Sale Insiders
High Sales Frequency
1Y PURCHASE DISTRIBUTION
purchase distribution by individual insiders
No Insider Trades made
0%
DIRECTORS
0%
OFFICERS
0%
10% OWNERS
0%
OTHERS
SHARES GINI INDEX Sector Average | N/A 0.2 |
VALUE GINI INDEX Sector Average | N/A 0.206 |
1Y SALE DISTRIBUTION
sale distribution by individual insiders
43.61%
DIRECTORS
28.43%
OFFICERS
27.96%
10% OWNERS
0%
OTHERS
SHARES GINI INDEX Sector Average | 0.291 0.295 |
VALUE GINI INDEX Sector Average | 0.269 0.288 |
NEKTAR THERAPEUTICS 1Y Trade Transactions
Submission Date Period of Report | Insider | Position | Total Value | Shares | Share Price | Ownership % Change | Shares Owned | Post Day Stock Change | Post Week Stock Change | |
|---|---|---|---|---|---|---|---|---|---|---|
2024-11-20 2024-11-19 | Zalevsky Jonathan | Officer | -$7,863 | 7,785 | $1.01 | -3.1% | 243,019 | N/A | N/A | |
2024-11-20 2024-11-19 | Wilson Mark Andrew | Officer | -$6,471 | 6,407 | $1.01 | -2.84% | 218,856 | N/A | N/A | |
2024-11-20 2024-11-19 | ROBIN HOWARD W | Director | -$16,441 | 16,278 | $1.01 | -1.92% | 832,490 | N/A | N/A | |
2024-08-20 2024-08-19 | Zalevsky Jonathan | Officer | -$8,788 | 6,866 | $1.28 | -2.66% | 250,804 | -0.78% | -2.34% | |
2024-08-20 2024-08-19 | Wilson Mark Andrew | Officer | -$7,233 | 5,651 | $1.28 | -2.45% | 225,263 | -0.78% | -2.34% | |
2024-08-20 2024-08-19 | ROBIN HOWARD W | Director | -$19,048 | 14,881 | $1.28 | -1.72% | 848,768 | -0.78% | -2.34% | |
2024-06-14 2024-06-14 | CHESS ROBERT | Director | -$23,400 | 19,500 | $1.2 | -6.94% | 261,573 | 0.00% | -0.85% | |
2024-05-20 2024-05-17 | ROBIN HOWARD W | Director | -$29,138 | 16,650 | $1.75 | -1.89% | 863,649 | -2.86% | -14.29% | |
2024-05-20 2024-05-17 | Zalevsky Jonathan | Officer | -$12,871 | 7,355 | $1.75 | -2.78% | 257,670 | -2.86% | -14.29% | |
2024-05-20 2024-05-17 | Wilson Mark Andrew | Officer | -$10,955 | 6,260 | $1.75 | -2.64% | 230,414 | -2.86% | -14.29% |